New diabetes clinical trial: Comparison of Exposure and Activity of SAR341402 Mix 70/30 to NovoLog Mix 70/30, NovoMix 30 and SAR341402 Rapid-acting Solution in Patients With Type 1 Diabetes Mellitus

Published on: April 16, 2019 at 09:30PM
Condition:   Type 1 Diabetes
Interventions:   Drug: SAR341402;   Drug: Insulin Aspart
Sponsor:   Sanofi
Completed
http://bit.ly/2PbZQEZ